The Company intends to submit a Biologics License Application (BLA) for TARA-002 in Lymphatic Malformations (LMs) in 2H 2027Hosting virtual ...

Keytruda aids Merck's Q1 performance with $8B in sales. New indications plus combo therapies could fuel the drug's overall growth through 2026.

Biotech stocks tied to cancer, autoimmune and rare disease therapies gain attention as M&A activity boosts sector sentiment.

Operator: Good afternoon, and welcome to Relmada Therapeutics First Quarter Earnings Conference Call. At this time, all ...

Diving into the overlooked role of pelvic floor health in overall wellness.

Up to half of all women will experience some degree of pelvic organ prolapse in their lifetime. The condition can cause ...

KEYMAKER-U04 substudy 04B: First-line (1L) enfortumab vedotin (EV) plus pembrolizumab (pembro)-based immune checkpoint inhibitor (ICI) combinations for advanced urothelial cancer (UC).

Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026: Rahway, New Jersey Wednesday, May 13, 2026, 11:00 Hrs [IST ...

A young woman from Portsmouth has told how ketamine took over her life - leaving her with angina, pneumonia, a hernia and ...

Highly, highly recommend giving these a try if you’ve got stubborn plantar warts." — Liz Dube Get a pack of 14 from Amazon ...